FIELD: biotechnology.
SUBSTANCE: invention relates to the field of biotechnology, in particular to an isolated antibody to a lectin-like of oxidized low-density lipoprotein receptor 1 (hereinafter – LOX1) or its fragment, which specifically bind LOX1, a composition containing it, as well as to a method for its preparation. An isolated nucleic acid molecule encoding the specified antibody to LOX1 or its fragment, as well as a vector and a cell containing it, are also disclosed.
EFFECT: invention is effective for the treatment of a disease or a condition associated with LOX1.
26 cl, 10 dwg, 10 tbl, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| GLUCAGON RECEPTOR BINDING PROTEINS AND METHODS OF USE THEREOF | 2018 |
|
RU2820628C2 |
| ANTI-SIRPα ANTIBODY AND USE THEREOF | 2021 |
|
RU2822496C1 |
| C3 BINDING AGENTS AND METHODS OF THEIR USE | 2019 |
|
RU2802307C2 |
| COMBINATIONS OF ANTIBODIES TO STAPHYLOCOCCUS AUREUS | 2019 |
|
RU2804815C2 |
| BISPECIFIC ANTIBODY | 2020 |
|
RU2814713C2 |
| BINDING MOLECULES SPECIFIC FOR CD73, AND METHODS OF THEIR APPLICATION | 2015 |
|
RU2730665C2 |
| ADVANCED PROCOAGULANT ANTIBODIES | 2019 |
|
RU2810748C2 |
| ANTIBODIES TARGETING B-CELL MATURATION ANTIGEN AND METHODS OF THE USE THEREOF | 2015 |
|
RU2766094C2 |
| ANTIBODIES BINDING TO PD-1 AND THEIR APPLICATIONS | 2019 |
|
RU2773758C2 |
| PD-1 BINDING ANTIBODIES AND METHODS OF THEIR USE | 2019 |
|
RU2812280C1 |
